Clinical trial
Combination Chemotherapy Plus Trastuzumab in Treating Patients With Advanced…
NCT00006015 · National Cancer Institute (NCI), NIH · Terminated
Key facts
| NCT number | NCT00006015 |
|---|---|
| Title | Combination Chemotherapy Plus Trastuzumab in Treating Patients With Advanced, Recurrent, or Metastatic Colorectal Cancer |
| Official title | Phase II Study Evaluating the Combination of 5-Fluorouracil, Leucovorin, Oxaliplatin, and Herceptin in the Treatment of Patients With Metastatic Colorectal Cancer Who Have Progressed After 5-FU and/or Irinotecan-Containing Therapy |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Biological, Drug |
| Interventions | trastuzumab, fluorouracil, leucovorin calcium, oxaliplatin |
| Enrollment | 26 |
| Start date | May 1, 2000 |
| Primary completion | Dec 1, 2002 |
| Completion | Feb 1, 2003 |
| First posted | Jan 27, 2003 |
| Last update posted | May 3, 2013 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: